Chromosome 13q DuplicationSymptoms, Doctors, Treatments, Advances & More
Chromosome 13q Duplication Overview
Learn About Chromosome 13q Duplication
- Chromosome 13q duplication
- 13q duplication
- 13q trisomy
- Duplication 13q
- Partial trisomy 13q
- Trisomy 13q
Duke Perinatal Consultants Of Cary
Sarah Dotters-Katz is a Neonatologist and an Obstetrics and Gynecologist practicing medicine in Cary, North Carolina. Dr. Dotters-Katz is rated as an Elite provider by MediFind in the treatment of Chromosome 13q Duplication. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Trisomy 13, Chromosome 13q Duplication, Trisomy 18, Hysterectomy, and Tubal Ligation. Dr. Dotters-Katz is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Preventative Medicine, Maternal & Fetal Medicine. Dr. Dotters-Katz is currently accepting new patients.
Center For Complex Obstetric Medicine
Mary Norton is a Neonatologist and a Medical Genetics provider practicing medicine in San Francisco, California. Dr. Norton is rated as a Distinguished provider by MediFind in the treatment of Chromosome 13q Duplication. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Alpha Thalassemia, and Hemolytic Disease of the Newborn. Dr. Norton is board certified in American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology, American Board Of Medical Genetics And Genomics, Clinical Genetics And Genomics, and American Board Of Obstetrics And Gynecology, Maternal-Fetal Medicine. Dr. Norton is currently accepting new patients.
Chih-ping Chen practices practicing medicine in Taiwan. Chen is rated as an Elite expert by MediFind in the treatment of Chromosome 13q Duplication. They are also highly rated in 124 other conditions, according to our data. Their clinical expertise encompasses Trisomy 14 Mosaicism, Mosaicism, Trisomy 2 Mosaicism, and Chromosome 13q Duplication.
Summary: The goal of the ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) study is to compare the concordance of results of a novel non-invasive circulating fetal cell (CFC) assay to the results of prenatal invasive diagnostic testing or postnatal genetic and clinical diagnosis of the resulting neonate. This is a prospective study of pregnant individuals.
Summary: Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD). Participants: Participants include 120 adults with ID, their caregivers, and their coaches (up to 360 individual participants, grouped as triads), recr...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

